These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11043085)

  • 1. New insights into genetic aspects of Alzheimer's disease. Does genetic information make a difference in clinical practice?
    Blacker D
    Postgrad Med; 2000 Oct; 108(5):119-22, 125-6, 129. PubMed ID: 11043085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic counseling and testing for families with Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
    Marshe VS; Gorbovskaya I; Kanji S; Kish M; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):65-85. PubMed ID: 30382407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
    van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
    Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.
    JAMA; 1995 Nov 22-29; 274(20):1627-9. PubMed ID: 7474250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
    Pérez-Tur J; Campion D; Martinez M; Brice A; Tardieu S; Hannequin D; Agid Y; Delacourte A; Clerget-Darpoux F; Chartier-Harlin MC
    Am J Med Genet; 1995 Dec; 60(6):550-3. PubMed ID: 8825894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE-epsilon 4 and early-onset Alzheimer's.
    Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
    Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.
    Roses AD
    Ann N Y Acad Sci; 1996 Dec; 802():50-7. PubMed ID: 8993484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing for Alzheimer's disease.
    Panegyres PK; Goldblatt J; Walpole I; Connor C; Liebeck T; Harrop K
    Med J Aust; 2000 Apr; 172(7):339-43. PubMed ID: 10844923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
    Mayeux R; Saunders AM; Shea S; Mirra S; Evans D; Roses AD; Hyman BT; Crain B; Tang MX; Phelps CH
    N Engl J Med; 1998 Feb; 338(8):506-11. PubMed ID: 9468467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E polymorphism and Alzheimer's disease.
    Yen YC; Liu CK; Lung FW; Chong MY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):190-7. PubMed ID: 11482130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].
    Alvarez V; Alvarez R; Peña J; Lahoz CH; Martínez C; Menéndez-Guisasola L; Salas-Puig J; Morís G; Uría D; Menes BB; Ribacoba R; Vidal JA; Coto E
    Med Clin (Barc); 1999 Oct; 113(12):441-3. PubMed ID: 10570509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease and genes].
    Jørgensen AL; Johannsen P
    Ugeskr Laeger; 1997 Sep; 159(38):5648-52. PubMed ID: 9340870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic predisposition for Alzheimer's disease].
    Staufenbiel M; Pombo-Villar E
    Ther Umsch; 1995 Dec; 52(12):821-5. PubMed ID: 8539654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E alleles as risk factors in Alzheimer's disease.
    Roses AD
    Annu Rev Med; 1996; 47():387-400. PubMed ID: 8712790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.